HB 466 Delaware House · 153rd General Assembly (2025-2026)

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE APPLICATION OF NASAL EPINEPHRINE.

Summary

This Act adds authority and guidelines for access to and use of intranasal epinephrine nasal sprays at institutions of higher education to the existing framework for access to and use of epinephrine injectors. This Act also removes the requirement of the Department of Public Health from filing an annual report regarding the use of epinephrine autoinjectors for the prior academic year with the General Assembly under this section.

Bill status signed all 5 stages cleared

Introduction

Jun 2026

Committee Review

Jun 2026

House Passage

Jun 2026

Senate Passage

Jun 2026

Signed into Law

Jul 2026

Introduced Jun 4, 2026 Signed Jul 23, 2026

Floor votes · Senate Jun 30, 2026 · House Jun 11, 2026

How they voted

21–0

Passed

Total votes 21

Jun 30, 2026

D Democratic15

15 Yea

100% Yea

R Republican6

6 Yea

100% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jul 23, 2026

Signed into law

Signed by Governor

executive

Jun 30, 2026

Upper · Passed

Passed By Senate. Votes: 21 YES

upper

Jun 24, 2026

Upper · Passed

Reported Out of Committee (Health & Social Services) in Senate with 6 On Its Merits

upper

Jun 11, 2026

Introduced

Assigned to Health & Social Services Committee in Senate

upper

Jun 11, 2026

Lower · Passed

Passed By House. Votes: 38 YES 1 NO 2 ABSENT

lower

Jun 9, 2026

Lower · Passed

Reported Out of Committee (Health & Human Development) in House with 1 Favorable, 10 On Its Merits

lower

Jun 4, 2026

Introduced

Introduced and Assigned to Health & Human Development Committee in House

lower

3 primary · 0 co-sponsors